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Abstract Federally qualified health centers (FQHCs)
offer primary and preventive healthcare, including cancer
screening, for the nation’s most vulnerable population. The
purpose of this study was to explore the relationship
between access to FQHCs and cancer mortality-to-inci-
dence ratios (MIRs). One-way analysis of variance was
conducted to compare the mean MIRs for breast, cervical,
prostate, and colorectal cancers for each U.S. county for
2006–2010 by access to FQHCs (direct access, in-county
FQHC; indirect access, adjacent-county FQHC; no access,
no FQHC either in the county or in adjacent counties).
ArcMap 10.1 software was used to map cancer MIRs and
FQHC access levels. The mean MIRs for breast, cervical,
and prostate cancer differed significantly across FQHC
access levels (p \ 0.05). In urban and healthcare profes-
sional shortage areas, mean MIRs decreased as FQHC
access increased. A trend of lower breast and prostate
cancer MIRs in direct access to FQHCs was found for all
racial groups, but this trend was significant for whites only.
States with a large proportion of rural and medically
underserved areas had high mean MIRs, with correspond-
ingly more direct FQHC access. Expanding FQHCs to
more underserved areas and concentrations of disparity
populations may have an important role in reducing cancer
morbidity and mortality, as well as racial-ethnic disparities,
in the United States.
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Introduction
Cancer is the second leading cause of death in the United
States, with an estimated 1.67 million new cases and
&585,720 deaths expected in 2014 [1]. Preventive health
care, including screening for primary prevention as well as
early detection for the down-staging of disease, is an
important tool for reducing cancer-related morbidity and
mortality. In addition, as advances in cancer detection and
treatment are realized, cancer survivors are living longer,
with many reverting back to their primary care provider for
long-term survivorship care.
In the United States, breast (for women), prostate (for
men), and colorectal cancers are the top three most com-
mon cancers [1]. In addition, all of these cancer types have
well-established screening tests that result in either disease
prevention (colorectal) [2] or early disease detection
(breast and prostate) [3, 4]. These same cancer types are
also the top three leading causes of cancer-related death
[1]. Similar to screening for colorectal cancer, cervical
cancer screening (e.g., pap smear test) is a primary pre-
vention technique that results in the complete removal of
premalignant lesions [5]. Although cervical cancer is not a
leading cause of cancer incidence or mortality in the
United States, there are significant proportions of minority
populations (African American, Latina, and individuals
from rural Appalachia) who suffer an unequal burden of
disease incidence and mortality for this cancer compared to
the general population [6–8]. For these reasons, it is vitally
important to monitor the burdens of disease within specific
geographic regions and racial groups.
Federally qualified health centers (FQHCs) are clinical
providers that serve a large proportion of underserved and
under-represented patients and are an important link to
providers of evidence-based approaches (e.g., cancer
screening) for cancer prevention and control. FQHCs, which
receive funding from the Health Resources and Services
Administration (HRSA), are important safety-net providers
of affordable, comprehensive preventive and primary health
care. FQHCs serve 20 million patients annually in the United
States, and nearly two-thirds of patients served at FQHCs are
ethnic minorities, low income, and uninsured [9]. FQHCs,
which implement the medical home model, have tremendous
potential to reduce health disparities for ethnic minorities
and other underserved populations by promoting easier care
transitions for patients [10]. As of 2012 in the United States,
1,198 FQHCs with 9,321 delivery sites offered preventive
and primary medical care, including cancer screening, aimed
at responding to disparities in healthcare access and health
status [10]. FQHCs are well positioned to reduce cancer
morbidity and mortality, as well as reduce health disparities,
a top priority of FQHCs [11]. With the passing of the
Affordable Care Act, the role of FQHCs to provide patient-
centered medical homes to diverse populations, including
those at risk for cancer and cancer survivors, has become
even more pivotal.
Mortality-to-incidence ratios (MIRs), when compared
across regions, provide a unique quantification of cancer
mortality disparities that takes into account incidence while
also describing mortality [5]. This measure ‘anchors’
mortality to a denominator that is limited to incident cancer
cases rather than the total population, as measured by
mortality rate. MIR is a valid indicator of fatality, and
studies have used MIRs to compare cancer rates across
populations [12, 13]. The MIR is particularly useful at
describing the true burden of disease among populations
and can be a useful comparison for both geographic and
racial groups.
The purpose of this descriptive analysis was to explore
the relationship between FQHC access and cancer MIRs at
the county level across the United States. We propose that
comparisons of MIRs across counties permit an assessment
of the relative efficiency of the local health system in
maximizing survival after cancer diagnosis given the
number of incident cases diagnosed in the geographic
regions surrounding FQHCs. We hypothesize that this
effect may be mediated as follows: to the extent that
FQHCs improve early cancer detection among medically
underserved populations in the county and navigate
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diagnosed patients for timely care by the appropriate care
providers, a county’s FQHC access level may lead to
greater cancer survivorship relative to other counties, as
reflected in the MIR.
Methods
Data Sources
Age-adjusted breast (female only), cervical, colorectal, and
prostate cancer mortality and incidence rates per 100,000
population for each US county for 2006–2010 were obtained
from the US National Cancer Institute’s (NCI) State Cancer
Profile website [14]. The number of FQHCs has been growing
steadily over the last decade. Therefore, the most easily
accessible data from FQHCs were used. Data on FQHCs in the
United States as of September 3, 2013 were downloaded from
the HRSA website. The data include the addresses of FQHC
delivery sites, including county information. FQHCs that (1)
were located in US territories (e.g., Guam or Puerto Rico), (2)
did not have address or county information, (3) provided only
administrative services, or (4) were not community health
centers were excluded from the analysis. FQHC delivery sites
that opened after 2010 were also excluded because they are
outside of the MIR time period (2006–2010). In the dataset,
there were 7,240 FQHC delivery sites for analysis. From the
2011–2012 Area Resource File, county information on urban
or rural designation, healthcare professional shortage areas
(HPSAs) for primary care in 2007 and socioeconomic status
(SES) indicators in 2005–2009, including median household
income, percentage of persons below the poverty level and
percentage of persons[25 years of age with a 4-year-college
degree, were obtained [15]. HPSAs for primary care at the
county level were measured using three categories: ‘‘none of
the county is a shortage area’’ (no-shortage area), ‘‘entire
county is a shortage area’’ (all-shortage area) or ‘‘part of the
county designated as a shortage area’’ (partial-shortage area)
[15]. Information on the percentage of households that do not
have a vehicle available was obtained from the 2006–2010
American Community Survey [16].
Primary Variables
Cancer mortality and incidence rates were suppressed if
there were less than three cases in a specific area-race cate-
gory. For example, if there were less than three whites who
were diagnosed with cervical cancer in a county, the inci-
dence rate for that cancer type was suppressed. Counties with
unknown, missing, or suppressed cancer mortality or inci-
dence rates were excluded. MIRs were calculated by divid-
ing the county-specific mortality rate by the county-specific
incidence rate [12]. The number of FQHC delivery sites was
summed for each county. Using ArcMap 10.1 (Esri, Red-
lands, CA), adjacent counties for each county were identi-
fied. To account for spatial correlation, we categorized
counties into three levels of access to FQHCs: (1) direct
access (any FQHC delivery sites in the county), (2) indirect
access (no FQHC delivery site in the county but any in
adjacent counties) or (3) no access (no FQHC delivery site
either in the county or any in adjacent counties).
Statistical Analysis
To quantify the potential impact of FQHC access on cancer
disparities, we compared mean MIRs by level of FQHC
access. County-specific MIRs were calculated for strata
defined by: household income distribution (above or below
the median for all counties), residential area (urban; rural),
HPSA designation (no-shortage area; partial-shortage area;
all-shortage area), and race (white; black). Other ethnic and
racial groups were excluded in the analysis because of
small sample sizes. All analyses were adjusted by county-
level SES indicators and the percentage of households that
do not have a vehicle available. One-way analysis of var-
iance was conducted to compare the mean MIRs in each
category of FQHC access. All analyses were conducted at
a = 0.05 level using SAS 9.3 (Cary, NC).
For mapping purposes, the mean MIRs of each cancer
and access to FQHCs were divided into six categories: high
MIR (above the median) with direct access; high MIR with
indirect access; high MIR with no access; low MIR with
direct access; low MIR with indirect access; and low MIR
with no access. In the figure, we used blue shading to
indicate direct access, green shading for indirect access,
and red shading for no access. High-MIR pairs are shown
in darker tones than low-MIR pairs. This MIR–FQHC
access categorization was mapped using ArcMap 10.1
(Esri, Redlands, CA) for each cancer.
Results
There were 1,612 counties with mortality and incidence rates
available for breast cancer, 234 for cervical cancer, 1,999 for
colorectal cancer, and 1,383 for prostate cancer. The overall
mean MIRs for breast, cervical, and prostate cancers were
significantly different by FQHC access level: counties with
direct access had lower cancer MIRs than those with indirect or
no access (p \ 0.05). Counties with indirect access had lower
MIRs than counties with no access, especially for breast cancer
MIRs. Counties in which the median household income is over
the aggregate median had lower cancer MIRs than counties
with lower median household income (Table 1).
In general, the mean MIRs for breast, colorectal, and
prostate cancers were higher in rural areas than in urban
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areas. In urban areas, the mean MIRs for the four cancers
decreased significantly as the level of FQHC access
increased (p \ 0.05); there were no significant differences
in rural areas, except for in breast cancer MIRs (Table 2).
When examined by HPSA designations, the mean MIRs
for breast, cervical, and prostate cancers significantly
decreased as the level of FQHC access increased among
counties identified as HPSAs (all or in part), although the
interaction between FQHC access level and HPSA desig-
nation was not statistically significant. However, there was
no significant association of cancer MIRs and access to
FQHC in the no-shortage areas (Table 3).
Blacks had higher mean MIRs for breast, cervical, and
prostate cancers than whites. A higher level of access to
FQHCs corresponded to lower MIRs for breast (p = 0.004)
and prostate (p = 0.019) cancers for whites only (Table 4).
Figure 1 shows US regional maps depicting access to
FQHC–MIR dyads for breast cancer. Additional maps for
colorectal and prostate cancers (Figure S1 & S2) are pro-
vided in the Appendix. Because of the large amount of
suppressed or missing cervical cancer MIR data, the map for
cervical cancer is not shown. In general, California, Florida,
and many Northeastern states had a high proportion of
counties with low cancer MIRs and direct access to FQHCs.
Conversely, Arizona, New Mexico, North Carolina, and
South Carolina (states with a large proportion of rural and
medically underserved areas) had a high proportion of
counties with high cancer MIRs and direct access to FQHCs.
Discussion
Results from this study are consistent with the hypothesized
mitigating effect of FQHCs in reducing mortality among
people diagnosed with cancer. The results were robust across
breast, cervical, and prostate cancers. FQHCs provide a
safety net for individuals who cannot afford healthcare and
disproportionately serve racial/ethnic minorities and low-
income populations who are more likely to be uninsured [9].
Because private primary care practitioners often limit or
refuse to take Medicaid and uninsured patients [17], FQHCs
are left as the key providers for these populations [18].
Furthermore, uninsured patients attending FQHC clinics
receive more preventive services than the average uninsured
person nationally, particularly pap tests and mammograms
[19]. Finally, it is acknowledged that FQHCs provide high-
quality care comparable to, or exceeding, that of other pri-
mary health care providers [20]. This study extends the
findings of earlier studies and may represent indirect evi-
dence that FQHCs have a far-reaching role in reducing
cancer mortality through providing cancer screening.
The inverse association between cancer MIRs and FQHC
access was observed more strongly in counties with a high
median household income. In our analyses, counties with
higher median household income generally had a greater
number of FQHC delivery sites than counties with a lower
median household income. This may have been partially
responsible for the findings upon stratification by median
household income.
Urban counties showed a stronger inverse association
between cancer MIRs and FQHC access. However, this
association was not apparent in rural counties. Although
rural households are more likely to possess private cars,
rural residents must travel longer distances to seek and
receive health care than their urban counterparts [21, 22].
Because rural residents are accustomed to traveling longer
distances, they might use health care services regardless of
FQHC existence in the surrounding area.
The inverse relationship between FQHC access and MIR
was strongest for breast, prostate, and cervical cancers and was
weaker for colorectal cancer. Cervical cancer screening is a
standard procedure in most FQHCs. Drawing of blood needed
to conduct prostate-specific antigen (PSA) screening is rela-
tively simple in the FQHC environment. In addition, many
FQHC sites are beginning to either offer mammography ser-
vices within their centers or have initiatives to streamline
referrals to mammography centers. By contrast, colorectal
cancer screening (namely colonoscopy) requires referral
arrangements for highly specialized services involving spe-
cialists and technology-intensive infrastructure. Sustaining
such referral arrangements for uninsured patients may be
challenging for FQHCs because of a lack of payer source.
There is also a significant burden on patients in preparations for
colonoscopy procedures (bowel prep and pre-surgical con-
sults). Another hypothesis may be that colonoscopy is a pri-
mary prevention measure (i.e., removing precancerous
lesions), and so potential cancer is identified before they can
progress to cancer. Hence the MIR statistic would not reflect
this premalignancy preventive measure. Additionally, with the
advent of PSA screening in the United States, prostate cancer
has tended to be diagnosed at early stages, and therefore has
been associated with generally longer survival [4, 23]. This
trend should be tempered with the recently updated recom-
mendations by the US Preventive Services Task Force, but
may have unique implications for high-risk minority groups
such as blacks [24]. In contrast to colorectal cancer, both cer-
vical and prostate cancers manifest the largest racial and
socioeconomic disparities among all common cancers [12, 25].
Colorectal cancer tends to be diagnosed at later stages, when
prognosis is poorer despite a greater effort made at preventing
death [26]. The fact that these results were strongest in HPSAs
suggests that FQHCs may be doing a particularly effective job
among individuals who would otherwise have poorer out-
comes after receiving a cancer diagnosis.
The analyses by race reveal interesting findings.
Although the MIRs for blacks most often showed the
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greatest reductions with higher health care access, these
reductions were not significant in this study. The number of
counties included in the analyses of cancer MIRs for blacks
is relatively small, which may account for the insignificant
findings. Nevertheless, breast, cervical, and prostate cancer
MIRs, regardless of FQHC access, were higher among
blacks than whites. The race-specific findings and HPSA
results, both, suggest the value of FQHCs at reducing
Table 1 MIRs for breast, cervical, colorectal, and prostate cancers
Cancer Total Under median household incomea Over median household income
# of counties Mean ± SE p # of counties Mean ± SE p # of counties Mean ± SE p
Breast
No accessb 59 0.224 ± 0.007 0.021 26 0.247 ± 0.012 0.099 33 0.203 ± 0.008 0.082
Indirect accessc 564 0.206 ± 0.002 297 0.220 ± 0.004 267 0.193 ± 0.003
Direct accessd 989 0.204 ± 0.002 482 0.221 ± 0.003 507 0.187 ± 0.002
Cervix
No access 0 NA 0 NA 0 NA
Indirect access 13 0.423 ± 0.027 <0.001 6 0.507 ± 0.042 <0.001 7 0.337 ± 0.032 0.230
Direct access 221 0.318 ± 0.006 111 0.340 ± 0.010 110 0.297 ± 0.008
Colorectal
No access 102 0.389 ± 0.008 0.407 46 0.401 ± 0.013 0.702 56 0.379 ± 0.010 0.559
Indirect access 744 0.395 ± 0.003 387 0.408 ± 0.005 357 0.382 ± 0.004
Direct access 1,153 0.390 ± 0.002 566 0.404 ± 0.004 587 0.376 ± 0.003
Prostate
No access 35 0.188 ± 0.011 0.026 15 0.236 ± 0.018 0.120 20 0.150 ± 0.012 <0.001
Indirect access 458 0.193 ± 0.003 241 0.206 ± 0.005 217 0.181 ± 0.004
Direct access 890 0.183 ± 0.002 435 0.200 ± 0.003 455 0.165 ± 0.002
Bold values indicate statistical significant (p \ 0.05)
MIR Mortality-to-Incidence Ratio, SE Standard Error, NA Data not available
a Median household income: breast cancer $43,317; cervical cancer $51,645; colorectal cancer: $42,397; prostate cancer: $44,172
b No FQHC delivery site both in the county and adjacent counties
c No FQHC delivery site in the county, but any in adjacent counties
d Any FQHC delivery sites in the county
Table 2 MIRs for breast,
cervical, colorectal, and prostate
cancers, by urban/rural
Bold values indicate statistical
significant (p \ 0.05)
MIR Mortality-to-Incidence
Ratio, SE Standard Error, NA
Data not available
a No FQHC delivery site both
in the county and adjacent
counties
b No FQHC delivery site in the
county, but any in adjacent
counties
c Any FQHC delivery sites in
the county
Urban Rural
# of counties Mean ± SE p # of counties Mean ± SE p
Breast
No accessa 9 0.253 ± 0.015 <0.001 50 0.231 ± 0.009 0.160
Indirect accessb 228 0.201 ± 0.003 336 0.214 ± 0.003
Direct accessc 590 0.191 ± 0.002 399 0.218 ± 0.003
Cervix
No access 0 NA 0 NA
Indirect access 11 0.416 ± 0.028 <0.001 2 0.583 ± 0.068 0.235
Direct access 216 0.314 ± 0.006 5 0.438 ± 0.038
Colorectal
No access 13 0.413 ± 0.020 0.028 89 0.394 ± 0.010 0.821
Indirect access 256 0.390 ± 0.005 488 0.401 ± 0.004
Direct access 622 0.377 ± 0.003 531 0.401 ± 0.004
Prostate
No access 5 0.225 ± 0.025 <0.001 30 0.202 ± 0.013 0.919
Indirect access 196 0.187 ± 0.004 262 0.202 ± 0.004
Direct access 562 0.169 ± 0.002 328 0.200 ± 0.004
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cancer morality while making the case for expansions of
services and programs to further reduce such disparities.
There are limitations that should be considered when
interpreting these findings. First, this is a descriptive,
ecological study, therefore, other unmeasured factors that
influence cancer incidence and mortality at the individual
level cannot be controlled. Consequently, although our
work certainly details areas for further research, our con-
clusion must be framed from a perspective of hypothesis
generation and should not be interpreted as causal.
Table 3 MIRs for breast, cervical, colorectal, and prostate cancers, by HPSA designation
No HPSA Partial HPSA All HPSA
# of counties Mean ± SE p # of counties Mean ± SE p # of counties Mean ± SE p
Breast
No accessa 30 0.212 ± 0.009 0.278 11 0.238 ± 0.014 0.049 18 0.236 ± 0.015 0.099
Indirect accessb 251 0.199 ± 0.003 163 0.204 ± 0.004 150 0.216 ± 0.005
Direct accessc 155 0.205 ± 0.004 448 0.202 ± 0.002 386 0.208 ± 0.003
Cervix
No access 0 NA 0 NA 0 NA
Indirect access 9 0.342 ± 0.042 0.906 2 0.427 ± 0.072 0.148 2 0.601 ± 0.049 <0.001
Direct access 9 0.349 ± 0.031 115 0.321 ± 0.009 90 0.312 ± 0.007
Colorectal
No access 47 0.387 ± 0.011 0.959 27 0.376 ± 0.016 0.258 28 0.407 ± 0.016 0.376
Indirect access 304 0.383 ± 0.004 215 0.399 ± 0.006 225 0.404 ± 0.006
Direct access 172 0.384 ± 0.006 504 0.389 ± 0.004 477 0.395 ± 0.004
Prostate
No access 17 0.168 ± 0.014 0.558 8 0.201 ± 0.022 0.678 10 0.209 ± 0.021 0.007
Indirect access 210 0.184 ± 0.004 135 0.184 ± 0.005 113 0.209 ± 0.006
Direct access 130 0.182 ± 0.005 411 0.182 ± 0.003 349 0.186 ± 0.004
Bold values indicate statistical significant (p \ 0.05)
MIR Mortality-to-Incidence Ratio, SE Standard Error, NA Data not available, HPSA Healthcare Professional Shortage Area
a No FQHC delivery site both in the county and adjacent counties
b No FQHC delivery site in the county, but any in adjacent counties
c Any FQHC delivery sites in the county
Table 4 MIRs for breast,
cervical, colorectal, and prostate
cancers, by race
Bold values indicate statistical
significant (p \ 0.05)
MIR Mortality-to-Incidence
Ratio, SE Standard Error, NA
Data not available
a No FQHC delivery site both
in the county and adjacent
counties
b No FQHC delivery site in the
county, but any in adjacent
counties
c Any FQHC delivery sites in
the county
Cancer Whites Blacks
# of counties Mean ± SE p # of counties Mean ± SE p
Breast
No accessa 55 0.221 ± 0.007 0.004 0 0.390
Indirect accessb 522 0.201 ± 0.002 38 0.274 ± 0.012
Direct accessc 889 0.196 ± 0.002 272 0.264 ± 0.004
Cervix
No access 0 NA 0 NA
Indirect access 5 0.368 ± 0.035 0.061 0 NA
Direct access 172 0.301 ± 0.006 46 0.436 ± 0.013
Colorectal
No access 99 0.389 ± 0.009 0.269 0 0.674
Indirect access 706 0.394 ± 0.003 12 0.377 ± 0.028
Direct access 1,067 0.387 ± 0.003 177 0.389 ± 0.007
Prostate
No access 30 0.184 ± 0.011 0.019 0 0.932
Indirect access 397 0.187 ± 0.003 26 0.271 ± 0.018
Direct access 772 0.175 ± 0.002 246 0.270 ± 0.006
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However, we should underscore that this ecologic investi-
gation is an important descriptive analysis that begins to
explore the larger implications of FQHCs on cancer sta-
tistics. Second, because of the county-level cancer inci-
dence and mortality data used, the data cannot account for
those individuals who may move after their cancer
diagnosis. We would expect this type of population drift to
be similar across most states, thereby lessening its potential
impact on the study findings. Additionally, most state
cancer registries have reciprocal data-sharing agreements
with neighboring states, thereby minimizing this potential
for bias further.
Fig. 1 Access to FQHCs and breast cancer MIRs by region. a West, b Midwest, c Northeast, d Southwest, e Southeast
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Despite the limitations, this investigation highlights the
potential impact of FQHCs further ‘downstream’ in terms of
cancer mortality, as well as their impact on more proximal
factors such as cancer surveillance and detection. Other more
expensive and much less practicable methodologies would be
needed to conduct more detailed levels of analysis. Another
important consideration when using the MIR statistic is the
time lag between cancer mortality and incidence. For this
analysis, overlapping periods of incidence and mortality were
used; however, non-virulent cancers (particularly breast and
prostate) developing within the later years of the incidence
period would not be reflected in the mortality period. This
research team previously conducted a sensitivity analysis
utilizing non-overlapping periods of time to account for the
impact of extended survival times. The results remained
unchanged from what was found previously with overlapping
periods [12]. After some debate concerning the most appro-
priate time point to measure FQHC access relative to cancer
MIRs, current FQHC data were chosen for this study. Sensi-
tivity analyses using alternative time points for FQHC access
were conducted, with no change in the original findings.
This study has several strengths. By grouping counties
according to FQHC access in neighboring counties, we
were able to account for spatial correlation. Additionally,
the variability in race-specific cancer MIRs that we found
may be higher than that in centers or studies serving pre-
dominantly white populations, such as university teaching
hospitals or established cohorts. The NCI’s State Cancer
Profile data provided a very robust, objective source for
estimating MIRs. Not only did it provide data from a large
sample of counties, but it also incorporated data over
multiple years (2006–2010). The selection of this database
resulted in rates that are more stable and robust than those
obtained from data covering fewer years and from a
smaller geographical sampling frame. Using these readily
available data, it revealed that FQHCs may have a mod-
erate impact on cancer mortality by influencing outcomes
among individuals with a cancer diagnosis.
In conclusion, this work highlights the potential impact of
FQHCs on such ‘downstream’ outcomes as cancer and
cancer disparities. To reduce disparities in healthcare access
and improve health outcomes to poor and underserved pop-
ulations, the role of FQHCs in providing quality and com-
prehensive preventive and primary healthcare services needs
to be further supported across several levels, including policy
and environmental facilitation. Continued partnerships
between academic institutions, FQHCs, and other affiliated
organizations (e.g., regional and national membership asso-
ciations) are one of the avenues in support of this goal. In
these partnerships, FQHC administration and healthcare
providers bring a ‘real life/in the trenches’ perspective and
pose research questions to traditional academic research,
enabling greater translation and benefit of research findings
into practice. Alternatively, academic institutions provide
expertise in research, which enables them to enhance the
quality and scope of services they provide.
To our knowledge, this is the first linkage of these geo-
graphic data to investigate the relationship between FQHC
access and MIRs. Such ecologic analyses of geographic data
are an important way to evaluate health care reform issues,
and offer great potential to understand the implications of
health policy, health care investments, and natural experi-
ments. Similar research should be conducted to determine
whether these findings generalize to other health issues.
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